Identification of Biomarkers in Spinocerebellar Ataxia 3

计划入组 22 人 · 首次发布于 2019 年 3 月 21 日

rTMS Improves Functions in Spinocerebellar Ataxia

计划入组 10 人 · 首次发布于 2023 年 8 月 2 日

Deep Brain Stimulation for Spinocerebellar Ataxia

计划入组 5 人 · 首次发布于 2025 年 12 月 17 日

Spinocerebellar ataxia(Retrotope)

Spinocerebellar Ataxia Type 3(CRD)

gene splicing modulator (spinocerebellar ataxia type 3)

FRIEDREICH'S ATAXIA RESEARCH ALLIANCE

United States

Lexeo Therapeutics

United States

Alaxia SAS

France

Biohaven Withdraws EU Application for Spinocerebellar Ataxia Drug Dazluma

FDA Grants Priority Review to Troriluzole for Spinocerebellar Ataxia Treatment

L-Arginine Shows Promise but Falls Short of Statistical Significance in Spinocerebellar Ataxia Type 6 Trial